CLINICAL TRIALS PROFILE FOR ARFORMOTEROL TARTRATE
✉ Email this page to a colleague
All Clinical Trials for arformoterol tartrate
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00250679 ↗ | Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease | Completed | Sunovion | Phase 3 | 2005-10-01 | To evaluate the long-term safety and monitor the long-term efficacy of arformoterol over a period of 6 months in subjects with chronic obstructive pulmonary disease (COPD). |
NCT00424528 ↗ | Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD) | Completed | Sunovion | Phase 4 | 2006-12-01 | The purpose of this study is to evaluate and compare the efficacy of arformoterol twice a day and tiotropium once a day (dosed sequentially) versus tiotropium once a day alone in subjects with Chronic Obstructive Pulmonary Disease (COPD). |
NCT00571428 ↗ | Efficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPD | Completed | Sunovion | Phase 4 | 2007-11-01 | To evaluate the efficacy and safety of arformoterol tartrate inhalation solution 30μg/4mL QD (two 15μg/2mL dosed in combination) over a 24-hour period compared to arformoterol tartrate inhalation solution 15μg/2 mL BID in subjects with COPD. |
NCT00583947 ↗ | A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects | Completed | Sunovion | Phase 2 | 2008-01-01 | To determine the safety and tolerability of Arformoterol Tartrate in children with asthma |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for arformoterol tartrate
Condition Name
Clinical Trial Locations for arformoterol tartrate
Trials by Country
Clinical Trial Progress for arformoterol tartrate
Clinical Trial Phase
Clinical Trial Sponsors for arformoterol tartrate
Sponsor Name